HighVista Strategies’s Core Scientific CORZ Stock Holding History

HighVista Strategies’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94M	Sell	75,712 -27,700	-27%	-$652K	0.44%	65
2026 Q1	$1.55M	Buy	103,412 +39,900	+63%	+$681K	0.43%	73
2025 Q4	$925K	Sell	63,512 -11,651	-16%	-$203K	0.24%	115
2025 Q3	$1.35M	Sell	75,163 -104,737	-58%	-$1.54M	0.33%	98
2025 Q2	$3.07M	Sell	179,900 -19,200	-10%	-$192K	1.13%	16
2025 Q1	$1.44M	Buy	199,100 +117,800	+145%	+$1.34M	0.56%	75
2024 Q4	$1.14M	Sell	81,300 -51,500	-39%	-$761K	0.42%	103
2024 Q3	$1.58M	Buy	+132,800	New	+$1.38M	0.54%	74

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

HighVista Strategies's CORZ Position: Q2 2026 in Review

HighVista Strategies reduced its Core Scientific (CORZ) stake by 27% in Q2 2026, selling an estimated $652K and leaving 75,712 shares worth $1.94M. The position accounts for 0.44% of the portfolio, ranked #65.

HighVista Strategies first reported a position in CORZ in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.07M in Q2 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

HighVista Strategies held 75,712 shares of Core Scientific worth $1.94M as of Q2 2026.
HighVista Strategies sold 27,700 Core Scientific shares in Q2 2026, an estimated $652K.
Core Scientific made up 0.44% of HighVista Strategies's portfolio in Q2 2026, its #65 holding.
HighVista Strategies first reported a position in Core Scientific in Q3 2024 and has held it in 8 quarters since.
HighVista Strategies's Core Scientific position peaked at $3.07M in Q2 2025.
413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.